| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/16/2009 | US20090099090 Of given sequence; human leukocyte antigen; induce cytotoxic T cells; use of them as cancer vaccines, and methods for treatment and prevention of cancers based on them |
| 04/16/2009 | US20090099088 System for Inhibiting Pathogenicity in the Rice-Blast Fungus Magnaporthe Grisea |
| 04/16/2009 | US20090099081 Synthetic axmi-004 delta-endotoxin genes and methods for their use |
| 04/16/2009 | US20090099079 Novel Fungal Enzymes |
| 04/16/2009 | US20090099078 Nogo Receptor Antagonists |
| 04/16/2009 | US20090099073 Albumin Fusion Proteins |
| 04/16/2009 | US20090099072 Motif of the Beclin Protein Which Interacts with Anti-Apoptotic Members of the Bcl-2 Protein Family, and Uses |
| 04/16/2009 | US20090099071 Sugar chain-containing albumin, production method thereof and use thereof |
| 04/16/2009 | US20090099060 Modulation of line-1 reverse transcriptase |
| 04/16/2009 | US20090099056 Protease Variants and Compositions |
| 04/16/2009 | US20090099043 Construction of pool of interfering nucleic acids covering entire RNA target sequence and related compositions |
| 04/16/2009 | US20090099037 Genomic Screen for Epigenetically Silenced Genes Associated With Cancer |
| 04/16/2009 | US20090099034 Reagents and Methods for miRNA Expression Analysis and Identification of Cancer Biomarkers |
| 04/16/2009 | US20090099033 In vitro screening and evolution of proteins |
| 04/16/2009 | US20090099031 Genetic package and uses thereof |
| 04/16/2009 | US20090099028 Protein binding miniature proteins and uses thereof |
| 04/16/2009 | US20090098654 Selectable genetic marker for use in pasteurellaceae species |
| 04/16/2009 | US20090098653 Transgenomic Mitochondria, Transmitochondrial Cells and Organisms, and Methods of Making and Using |
| 04/16/2009 | US20090098652 Self assembling peptide systems and methods |
| 04/16/2009 | US20090098650 Compositions for the in vitro derivation and culture of embryonic stem (es) cell lines with germline transmission capability and for the culture of adult stem cells |
| 04/16/2009 | US20090098647 Using recombination protein -A (recA), cell division, chaperonin and/or translation elongation factor Tu binding as indicator of microorganismal infection |
| 04/16/2009 | US20090098634 Scleroprotein of an adeno associated virus with modified chromatographic properties, the production thereof and use of the same |
| 04/16/2009 | US20090098632 Compositions comprising viruses and methods for concentrating virus preparations |
| 04/16/2009 | US20090098631 Novel glutamic acid decarboxylase (GAD) proteins and methods of use |
| 04/16/2009 | US20090098630 Fusion protein, gene related to fusion protein, vector, transformants, and anti-inflammatory medicinal composition |
| 04/16/2009 | US20090098629 Comprises urogenital system specific protein for diagnosing and treating tumors; antiproliferative agents; genetic vaccine; 22P4F11 transcript and/or protein represent a useful diagnostic marker and/or therapeutic target for prostate cancer |
| 04/16/2009 | US20090098626 Nucleic acids encoding modified cytochrome p450 enzymes and methods of use thereof |
| 04/16/2009 | US20090098622 Schizochytrium pks genes |
| 04/16/2009 | US20090098615 Genetically modified cells and methods for converting (r)-methylmalonyl coa to (s)-methylmalonyl coa |
| 04/16/2009 | US20090098614 Useful in the design of improved RNAi-mediating agents which allow for more exact control of the efficacy of RNA silencing; enhancing silencing of a target mRNA |
| 04/16/2009 | US20090098611 Self-cleaving affinity tags and methods of use |
| 04/16/2009 | US20090098610 useful as a reagent for genetic engineering, DNA sequencing, labeling, site-directed mutagenesi; culturing a cell capable of producing a polypeptide, and collecting such polypeptide from the culture |
| 04/16/2009 | US20090098608 Methods, systems and reagents for improved immunodetection |
| 04/16/2009 | US20090098607 Production of recombinant human hemoglobin using pichia yeast |
| 04/16/2009 | US20090098606 Cultivating mutant Bacillus licheniformis cell transformed with nucleic acid construct comprising nucleic acid directing synthesis of heterologous protein in suitable medium, where mutant cell comprises deletion mutation in cypX gene or yvmC gene in which mutation renders cell deficient in red pigment |
| 04/16/2009 | US20090098604 host cells; tumor antigens; for treatment, prevention of cancer |
| 04/16/2009 | US20090098603 Polypeptides sharing sequence identity with a fibroblast growth factor polypeptide and nucleic acids encoding the same |
| 04/16/2009 | US20090098602 nucleic acid sequence encoding mHKcel; used as an additive in a detergent composition, in the treatment of cellulose containing fabrics, in the treatment of pulp and paper and in the treatment of starch for the production of high fructose corn-syrup or ethanol |
| 04/16/2009 | US20090098601 Selection of Host Cells Expressing Protein at High Levels |
| 04/16/2009 | US20090098600 Thermotolerant ribonuclease h |
| 04/16/2009 | US20090098599 Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use |
| 04/16/2009 | US20090098592 Method |
| 04/16/2009 | US20090098580 Mammalian sweet taste receptors |
| 04/16/2009 | US20090098579 Using g-protein coupled receptor as tools in identifying modulators which improve palatability of low-calorie beverages through development of new artificial sweeteners; modulating taste perception |
| 04/16/2009 | US20090098573 for use in designing and/or identifying modulators of insect behavior; biolgical pest control |
| 04/16/2009 | US20090098571 Methods and substances for the diagnosis and therapy of sepsis and sepsis-like systemic infections |
| 04/16/2009 | US20090098570 Lxr ligand testing method |
| 04/16/2009 | US20090098569 Novel PGC-1 Isoforms and Uses Therefor |
| 04/16/2009 | US20090098566 Method of synthesizing nucleic acid |
| 04/16/2009 | US20090098561 Higher-order cellular information processing devices |
| 04/16/2009 | US20090098558 Detection, identification and differentiation of proteus species using the spacer region |
| 04/16/2009 | US20090098546 Methods of Screening for LTRPC7 Modulators |
| 04/16/2009 | US20090098544 Marker molecules associated with lung tumors |
| 04/16/2009 | US20090098528 Method for determining early HCV seroconversion |
| 04/16/2009 | US20090098301 Solid support having electrostatic layer and use thereof |
| 04/16/2009 | US20090098249 Variant Buttiauxella sp. Phytases having altered properties |
| 04/16/2009 | US20090098243 Overexpressed and purified aspergillus ficuum oxidase and nucleic acid encoding the same |
| 04/16/2009 | US20090098164 Spore associated display |
| 04/16/2009 | US20090098154 Yeast-Based Vaccines As Immunotherapy |
| 04/16/2009 | US20090098153 Activation of HCV-specific T cells |
| 04/16/2009 | US20090098150 Anti-acetylated huntingtin antibodies and uses therof |
| 04/16/2009 | US20090098149 Transgenic algae for delivering antigens to an animal |
| 04/16/2009 | US20090098148 High efficiency tissue-specific compound delivery system using streptavadin-protein a fusion protein |
| 04/16/2009 | US20090098140 Monoclonal antibodies and their use |
| 04/16/2009 | US20090098134 Compositions and methods for inhibiting endogenous immunoglobulin genes and producing transgenic human idiotype antibodies |
| 04/16/2009 | US20090098132 Composition and method for treating lupus nephritis |
| 04/16/2009 | US20090098131 Compositions and methods for the treatment of immune related diseases |
| 04/16/2009 | US20090098129 Member of the TNF Ligand Family |
| 04/16/2009 | US20090098128 NPC1L1 orthologues |
| 04/16/2009 | US20090098126 Method and kit for the detection of adenoviruses |
| 04/16/2009 | US20090098125 PTHrP, its isoforms and antagonist thereto in the diagnosis and treatment of disease |
| 04/16/2009 | US20090098124 Identification and engineering of antibodies with variant heavy chains and methods of using same |
| 04/16/2009 | US20090098122 sRAGE Mimetibody, Compositions, Methods and Uses |
| 04/16/2009 | US20090098121 Monoclonal antibody fusion comprising bactericidal agent for use in targeted destruction of microorganisms; for use in health care, veterinary medicine and food processing |
| 04/16/2009 | US20090098120 Compositions and methods for the treatment of immune related diseases |
| 04/16/2009 | US20090098117 Composition comprising and method of using angiopoietin-like protein 3 angptl3 |
| 04/16/2009 | US20090098112 Novel antibodies |
| 04/16/2009 | US20090098111 Methods for modulating checkpoint activation through TopBP1 |
| 04/16/2009 | US20090098103 Modified factor VII polypeptides and uses thereof |
| 04/16/2009 | US20090098099 Bacillus thuringiensis strains comprising novel crystal proteins which exhibit insecticidal activity against lepidopteran insects |
| 04/16/2009 | US20090098089 Reovirus for the treatment of neoplasia |
| 04/16/2009 | US20090098056 Alpk1 gene variants in diagnosis risk of gout |
| 04/16/2009 | US20090098053 La1 - the genome of a lactobacillus strain |
| 04/16/2009 | US20090098051 Bacillus thuringiensis toxin |
| 04/16/2009 | US20090098049 Targeting transducible molecules to specific cell types |
| 04/16/2009 | US20090095624 Electroactive complex, electroactive probe and preparation method |
| 04/16/2009 | DE19960271B4 Sarcosinoxidase und Verfahren zu deren Herstellung Sarcosine oxidase, and process for their preparation |
| 04/16/2009 | DE19520398B4 Magnetisches Pigment Magnetic pigment |
| 04/16/2009 | DE102006024359B4 Tiermodell für das humane Immunsystem, sowie Verfahren zu dessen Herstellung Animal model for the human immune system, and methods for its preparation |
| 04/16/2009 | CA2702400A1 Mite antigenic rice |
| 04/16/2009 | CA2702361A1 Microorganism engineered to produce isopropanol |
| 04/16/2009 | CA2702231A1 Synthetic genes encoding cry1ac |
| 04/16/2009 | CA2702217A1 Modulation of sirp.alpha. - cd47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor |
| 04/16/2009 | CA2702212A1 Methods for assaying mc1r variants and mitochondrial markers in skin samples |
| 04/16/2009 | CA2702206A1 Methods of controlling plant seed and organ size |
| 04/16/2009 | CA2702180A1 Method for opening tight junctions |
| 04/16/2009 | CA2702120A1 Compositions and methods for improved glycoprotein sialylation |
| 04/16/2009 | CA2702061A1 System and method for producing synthetic microorganisms capable of translating proteins containing non-standard amino acids |
| 04/16/2009 | CA2702058A1 Engineered dendritic cells and uses for the treatment of cancer |
| 04/16/2009 | CA2702035A1 Udp-glucuronyl transferase and polynucleotide encoding the same |